SCHEMBL8739760

SCHEMBL8739760

c1cc[n+](CCCC[n+]2ccccc2)cc1

nearest known ligand 0.93

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
BCHE P06276 7/20 0.93
ACHE P22303 7/20 0.93

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3589030 0.97 BCHE (1.00) BCHEACHE
SCHEMBL3589499 0.97 BCHE (1.00) BCHEACHE
SCHEMBL3605494 0.97 BCHE (1.00) BCHEACHE
SCHEMBL4880272 0.97 BCHE (1.00) BCHEACHE
Hydrochloric Acid SCHEMBL9815893 0.97 BCHE (0.88) BCHEACHE
SCHEMBL3609657 0.97 BCHE (1.00) BCHEACHE
SCHEMBL3599570 0.97 BCHE (1.00) BCHEACHE
SCHEMBL3598000 0.97 BCHE (1.00) BCHEACHE
Bromide SCHEMBL3591238 0.94 BCHE (1.00) BCHEACHE
Bromide SCHEMBL9764843 0.94 BCHE (1.00) BCHEACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230183489-A1 COLORING COMPOSITION, INK JET RECORDING METHOD, IMAGE RECORDED MATERIAL, AND COLORING AGENT COMPOUND FUJIFILM CORPORATION (JP) 2023-06-15 US disclosed
US-9839591-B2 Anionic dye or brightener bearing an ammonium or phosphonium counterion, dye composition comprising them and process for dyeing keratin fibres using these dyes L'OREAL (FR) 2017-12-12 US disclosed
US-20150113742-A1 ANIONIC DYE OR BRIGHTENER BEARING AN AMMONIUM OR PHOSPHONIUM COUNTERION, DYE COMPOSITION COMPRISING THEM AND PROCESS FOR DYEING KERATIN FIBRES USING THESE DYES L'OREAL (FR) 2015-04-30 US disclosed
CN-102911071-B Super-molecule complex containing amino acid and water-solubility pillar [5] arene and preparation method for complex UNIV SHANGHAI 2015-02-25 CN disclosed
CN-102911071-A Super-molecule complex containing amino acid and water-solubility pillar [5] arene and preparation method for complex UNIV SHANGHAI 2013-02-06 CN disclosed
EP-2463266-A1 PROCESS FOR PRODUCTION OF BIS-QUATERNARY AMMONIUM SALT, AND NOVEL INTERMEDIATE Wako Pure Chemical Industries, Ltd. (JP) 2012-06-13 EP disclosed
US-20120130107-A1 PROCESS FOR PRODUCTION OF BIS-QUATERNARY AMMONIUM SALT, AND NOVEL INTERMEDIATE WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) 2012-05-24 US disclosed
US-7723011-B2 Support, protective layer of crosslinked polymer ionically crosslinkable; ethylenically unsaturated polymerization initiator, binder polymer, dye; direct plate-making negative-working lithographic printing plate precursor; directly making a plate with a laser from a digital signal of a computer FUJIFILM CORPORATION (JP) 2010-05-25 US disclosed
US-20080145782-A1 IMAGE RECORDING MATERIAL AND NOVEL COMPOUND FUJIFILM CORPORATION (JP) 2008-06-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150113742-A1 ANIONIC DYE OR BRIGHTENER BEARING AN AMMONIUM OR PHOSPHONIUM COUNTERION, DYE COMPOSITION COMPRISING THEM AND PROCESS FOR DYEING KERATIN FIBRES USING THESE DYES KRT18, IK, COL14A1 BCHE 2753/4885ACHE 2056/4885
US-20120130107-A1 PROCESS FOR PRODUCTION OF BIS-QUATERNARY AMMONIUM SALT, AND NOVEL INTERMEDIATE ASS1, C1S, FHIT BCHE 1488/4885ACHE 2788/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.